Vancouver, Canada · Founded 2018 · Privately Held (backing)
Developer of novel metallotherapeutics metal-based small molecules designed for the treatment of cancer. Bold Therapeutics is based in Vancouver, Canada and was founded in 2018. Its last known valuation is $140 million. It has raised $25 million across 1 recorded round; the latest was a $5.5 million early-stage round in Jul 2018.
Last price · $/share
—
Implied valuation
$140.0M
Total raised
$25.0M
Last round
Early Stage VC
Jul 2018
Cap table — not yet on record
Bold Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bold Therapeutics with a free account
·Watch Bold Therapeutics: the Monday email on marks, rounds and moves
Where does Bold Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Bold Therapeutics's 1 recorded funding rounds.
